(NASDAQ: PODD) Insulet's forecast annual revenue growth rate of 17.37% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.28%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.16%.
Insulet's revenue in 2024 is $1,697,100,000.On average, 9 Wall Street analysts forecast PODD's revenue for 2024 to be $137,302,177,661, with the lowest PODD revenue forecast at $135,524,455,828, and the highest PODD revenue forecast at $138,452,945,400. On average, 9 Wall Street analysts forecast PODD's revenue for 2025 to be $163,690,400,020, with the lowest PODD revenue forecast at $159,775,398,249, and the highest PODD revenue forecast at $169,318,162,622.
In 2026, PODD is forecast to generate $192,382,395,479 in revenue, with the lowest revenue forecast at $184,768,042,888 and the highest revenue forecast at $198,133,856,698.